Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

SCMP

Sucampo Pharmaceuticals, Inc. (delisted) (SCMP)

Sucampo Pharmaceuticals, Inc. (delisted)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SCMP
일자시간출처헤드라인심볼기업
2018/02/2322:27Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1620:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1620:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1620:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1620:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1606:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1606:41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1508:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1508:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1407:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1406:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1406:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1406:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1406:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1406:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1406:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1405:51Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1401:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1401:13Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1400:59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1400:55Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
2018/02/1400:53Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
 검색 관련기사 보기:NASDAQ:SCMP